Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (142)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goodman-Gruen, D.
Right arrow Articles by Barrett-Connor, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodman-Gruen, D.
Right arrow Articles by Barrett-Connor, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 145, No. 11: 970-976
Copyright © 1997 by The Johns Hopkins University School of Hygiene and Public Health


other

Epidemiology of Insulin-like Growth Factor-I in Elderly Men and Women: The Rancho Bernardo Study

Deborah Goodman-Gruen and Elizabeth Barrett-Connor

From the Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA

Reprint requests to Dr. Elizabeth Barrett-Connor, Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0628.

Insulin-like growth factor-l (IGF-I) is abundant in the circulation and has been shown to have a wide array of biologic effects. The authors carried out a cross-sectional community-based study of 420 men and 419 nonestrogen-using postmenopausal women aged 50–97 years to ascertain the within-person and laboratory reliability of IGF-I measurements, and the association of IGF-I with common epidemiologic confounders. There was no evidence of seasonal or diurnal variation. IGF-I decreased linearly with age in both sexes, with significantly lower levels in men than women (126.9 µg/liter vs. 134.1 µg/liter; p = 0.03). In age-adjusted analyses, IGF-I was not associated with height, total or central body fat, lean body mass, current smoking, physical activity, or commonly used medications. By contrast, in both men and women who reported any alcohol use, IGF-I levels were significantly higher compared with those in men and women who reported no alcohol use, and alcohol as a continuous variable showed a significant positive linear trend in men (p = 0.0007). The authors conclude that IGF-I varied significantly only with age, sex, and alcohol use. The minimal number of confounding variables, good reliability, and little intraindividual variation suggest that IGF-I should be suitable for epidemiologic research. Am J Epidemiol 1997; 145: 970-6.

aged; alcohol drinking; insulin-like growth factor I; sex


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. A. D'Aloisio, J. C. Schroeder, K. E. North, C. Poole, S. L. West, G. S. Travlos, and D. D. Baird
IGF-I and IGFBP-3 Polymorphisms in Relation to Circulating Levels among African American and Caucasian Women
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 954 - 966.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. M. Wolpin, J. A. Meyerhardt, A. T. Chan, K. Ng, J. A. Chan, K. Wu, M. N. Pollak, E. L. Giovannucci, and C. S. Fuchs
Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer
J. Clin. Oncol., January 10, 2009; 27(2): 176 - 185.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. W. Chu, Y. Zhu, K. Yu, T. Zheng, A. P. Chokkalingam, F. Z. Stanczyk, Y.-T. Gao, and A. W. Hsing
Correlation between Circadian Gene Variants and Serum Levels of Sex Steroids and Insulin-like Growth Factor-I
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3268 - 3273.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Siahpush, T. L. Vaughan, J. N. Lampe, R. Freeman, S. Lewis, R. D. Odze, P. L. Blount, K. Ayub, P. S. Rabinovitch, B. J. Reid, et al.
Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2387 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson
Body shape throughout life and correlations with IGFs and GH
Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Baglietto, D. R. English, J. L. Hopper, H. A. Morris, W. D. Tilley, and G. G. Giles
Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 763 - 768.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Verheus, P. H.M. Peeters, R. Kaaks, P. A.H. van Noord, D. E. Grobbee, and C. H. van Gils
Premenopausal Insulin-Like Growth Factor-I Serum Levels and Changes in Breast Density over Menopause
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. D. Henderson, M. I. Goran, L. N. Kolonel, B. E. Henderson, and L. Le Marchand
Ethnic Disparity in the Relationship between Obesity and Plasma Insulin-Like Growth Factors: The Multiethnic Cohort.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2298 - 2302.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. I. Okereke, J. H. Kang, J. Ma, J. M. Gaziano, and F. Grodstein
Midlife Plasma Insulin-Like Growth Factor I and Cognitive Function in Older Men
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4306 - 4312.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E. S Schernhammer, J. M Holly, D. J Hunter, M. N Pollak, and S. E Hankinson
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Missmer, D. Spiegelman, E. R. Bertone-Johnson, R. L. Barbieri, M. N. Pollak, and S. E. Hankinson
Reproducibility of Plasma Steroid Hormones, Prolactin, and Insulin-like Growth Factor Levels among Premenopausal Women over a 2- to 3-Year Period.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 972 - 978.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Bray, D. Gunnell, J. M. P. Holly, N. Middleton, G. D. Smith, and R. M. Martin
Associations of Childhood and Adulthood Height and the Components of Height with Insulin-Like Growth Factor Levels in Adulthood: A 65-Year Follow-Up of the Boyd Orr Cohort
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1382 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
M. Maggio, A. Ble, G. P. Ceda, and E. J. Metter
Decline in insulin-like growth factor-I levels across adult life span in two large population studies.
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2006; 61(2): 182 - 183.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler
Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter
Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1394 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. K. Wei, J. Ma, M. N. Pollak, N. Rifai, C. S. Fuchs, S. E. Hankinson, and E. Giovannucci
A Prospective Study of C-Peptide, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-1, and the Risk of Colorectal Cancer in Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Schernhammer, J. M. Holly, M. N. Pollak, and S. E. Hankinson
Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. A Lavigne, D. J Baer, H. H Wimbrow, P. S Albert, E. D Brown, J. T Judd, W. S Campbell, C. A Giffen, J. F Dorgan, T. J Hartman, et al.
Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva
Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus
The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. M. Gapstur, P. Kopp, B. C-H. Chiu, P. H. Gann, L. A. Colangelo, and K. Liu
Longitudinal Associations of Age, Anthropometric and Lifestyle Factors with Serum Total Insulin-Like Growth Factor-I and IGF Binding Protein-3 Levels in Black and White Men: the CARDIA Male Hormone Study
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2208 - 2216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. DeLellis, S. Rinaldi, R. J. Kaaks, L. N. Kolonel, B. Henderson, and L. Le Marchand
Dietary and Lifestyle Correlates of Plasma Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3): The Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1444 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. H. Lai, D. Vesprini, W. Zhang, M. J. Yaffe, M. Pollak, and S. A. Narod
A Polymorphic Locus in the Promoter Region of the IGFBP3 Gene Is Related to Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 573 - 582.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham
Association between Insulin-Like Growth Factor-I: Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 166 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Gunnell, S. E. Oliver, J. L. Donovan, T. J. Peters, D. Gillatt, R. Persad, F. C. Hamdy, D. E. Neal, and J. M. P. Holly
Do Height-Related Variations in Insulin-Like Growth Factors Underlie the Associations of Stature with Adult Chronic Disease?
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 213 - 218.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. S. Vasan, L. M. Sullivan, R. B. D'Agostino, R. Roubenoff, T. Harris, D. B. Sawyer, D. Levy, and P. W.F. Wilson
Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study
Ann Intern Med, October 21, 2003; 139(8): 642 - 648.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. M. Y. Nomura, G. N. Stemmermann, J. Lee, and M. N. Pollak
Serum Insulin-like Growth Factor I and Subsequent Risk of Colorectal Cancer among Japanese-American Men
Am. J. Epidemiol., September 1, 2003; 158(5): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. M. Probst-Hensch, H. Wang, V. H. H. Goh, A. Seow, H.-P. Lee, and M. C. Yu
Determinants of Circulating Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations in a Cohort of Singapore Men and Women
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 739 - 746.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Woodson, J. A. Tangrea, M. Pollak, T. D. Copeland, P. R. Taylor, J. Virtamo, and D. Albanes
Serum Insulin-like Growth Factor I: Tumor Marker or Etiologic Factor? A Prospective Study of Prostate Cancer among Finnish Men
Cancer Res., July 15, 2003; 63(14): 3991 - 3994.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. R. Cappola, Q.-L. Xue, L. Ferrucci, J. M. Guralnik, S. Volpato, and L. P. Fried
Insulin-Like Growth Factor I and Interleukin-6 Contribute Synergistically to Disability and Mortality in Older Women
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2019 - 2025.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. D. Borofsky, J. H. Vogelman, R. A. Krajcik, and N. Orentreich
Utility of Insulin-like Growth Factor-1 as a Biomarker in Epidemiologic Studies
Clin. Chem., December 1, 2002; 48(12): 2248 - 2251.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Spitz, M. J. Barnett, G. E. Goodman, M. D. Thornquist, X. Wu, and M. Pollak
Serum Insulin-like Growth Factor (IGF) and IGF-binding Protein Levels and Risk of Lung Cancer: A Case-Control Study Nested in the {beta}-Carotene and Retinol Efficacy Trial Cohort
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1413 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Holmes, M. N. Pollak, W. C. Willett, and S. E. Hankinson
Dietary Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 852 - 861.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Holmes, M. N. Pollak, and S. E. Hankinson
Lifestyle Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Teramukai, T. Rohan, H. Eguchi, T. Oda, K. Shinchi, and S. Kono
Anthropometric and Behavioral Correlates of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 in Middle-aged Japanese Men
Am. J. Epidemiol., August 15, 2002; 156(4): 344 - 348.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Chang, X. Wu, H. Yu, and M. R. Spitz
Plasma Concentrations of Insulin-like Growth Factors among Healthy Adult Men and Postmenopausal Women: Associations with Body Composition, Lifestyle, and Reproductive Factors
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 758 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Giovannucci
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
J. Nutr., November 1, 2001; 131(11): 3109S - 3120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Decensi, H. Johansson, R. Miceli, L. Mariani, T. Camerini, E. Cavadini, M. G. Di Mauro, A. Barreca, A. G. Gonzaga, S. Diani, et al.
Long-Term Effects of Fenretinide, a Retinoic Acid Derivative, on the Insulin-like Growth Factor System in Women with Early Breast Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1047 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. K. Cruickshank, A. H. Heald, S. Anderson, J. E. Cade, J. Sampayo, L. K. Riste, A. Greenhalgh, W. Taylor, W. Fraser, A. White, et al.
Epidemiology of the Insulin-like Growth Factor System in Three Ethnic Groups
Am. J. Epidemiol., September 15, 2001; 154(6): 504 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. R. Cappola, K. Bandeen-Roche, G. S. Wand, S. Volpato, and L. P. Fried
Association of IGF-I Levels with Muscle Strength and Mobility in Older Women
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4139 - 4146.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Stattin, A. Bylund, S. Rinaldi, C. Biessy, H. Dechaud, U.-H. Stenman, L. Egevad, E. Riboli, G. Hallmans, and R. Kaaks
Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study
J Natl Cancer Inst, December 6, 2000; 92(23): 1910 - 1917.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. Kaaks, P. Toniolo, A. Akhmedkhanov, A. Lukanova, C. Biessy, H. Dechaud, S. Rinaldi, A. Zeleniuch-Jacquotte, R. E. Shore, and E. Riboli
Serum C-Peptide, Insulin-Like Growth Factor (IGF)-I, IGF-Binding Proteins, and Colorectal Cancer Risk in Women
J Natl Cancer Inst, October 4, 2000; 92(19): 1592 - 1600.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Yu and T. Rohan
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Byrne, G. A. Colditz, W. C. Willett, F. E. Speizer, M. Pollak, and S. E. Hankinson
Plasma Insulin-like Growth Factor (IGF) I, IGF-binding Protein 3, and Mammographic Density
Cancer Res., July 1, 2000; 60(14): 3744 - 3748.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Giovannucci, M. N. Pollak, E. A. Platz, W. C. Willett, M. J. Stampfer, N. Majeed, G. A. Colditz, F. E. Speizer, and S. E. Hankinson
A Prospective Study of Plasma Insulin-like Growth Factor-1 and Binding Protein-3 and Risk of Colorectal Neoplasia in Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 345 - 349.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. A. Platz, M. N. Pollak, E. B. Rimm, N. Majeed, Y. Tao, W. C. Willett, and E. Giovannucci
Racial Variation in Insulin-Like Growth Factor-1 and Binding Protein-3 Concentrations in Middle-Aged Men
Cancer Epidemiol. Biomarkers Prev., December 1, 1999; 8(12): 1107 - 1110.
[Abstract] [Full Text]


Home page
JCOHome page
V. G. Kaklamani, A. Linos, E. Kaklamani, I. Markaki, Y. Koumantaki, and C. S. Mantzoros
Dietary Fat and Carbohydrates Are Independently Associated With Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 Concentrations in Healthy Adults
J. Clin. Oncol., October 1, 1999; 17(10): 3291 - 3298.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Ma, M. N. Pollak, E. Giovannucci, J. M. Chan, Y. Tao, C. H. Hennekens, and M. J. Stampfer
Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3
J Natl Cancer Inst, April 7, 1999; 91(7): 620 - 625.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
V. G. Kaklamani, A. Linos, E. Kaklamani, I. Markaki, and C. Mantzoros
Age, Sex, and Smoking Are Predictors of Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3
J. Clin. Oncol., March 1, 1999; 17(3): 813 - 813.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Yu, M. R. Spitz, J. Mistry, J. Gu, W. K. Hong, and X. Wu
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
J Natl Cancer Inst, January 20, 1999; 91(2): 151 - 156.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Langlois, C. J. Rosen, M. Visser, M. T. Hannan, T. Harris, P. W. F. Wilson, and D. P. Kiel
Association Between Insulin-Like Growth Factor I and Bone Mineral Density in Older Women and Men: The Framingham Heart Study
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4257 - 4262.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
S.-T. UH, Y. INOUE, T. E. KING Jr., E. D. CHAN, L. S. NEWMAN, and D. W. H. RICHES
Morphometric Analysis of Insulin-like Growth Factor-I Localization in Lung Tissues of Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1626 - 1635.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. Yu, S. A. Smith-Warner, D. Spiegelman, W. C. Willett, and D. J. Hunter
Alcohol Consumption and Breast Cancer Risk
JAMA, October 7, 1998; 280(13): 1138 - 1139.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. J. Rosen, E. S. Kurland, D. Vereault, R. A. Adler, P. J. Rackoff, W. Y. Craig, S. Witte, J. Rogers, and J. P. Bilezikian
Association Between Serum Insulin Growth Factor-I (IGF-I) and a Simple Sequence Repeat in IGF-I Gene: Implications for Genetic Studies of Bone Mineral Density
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2286 - 2290.
[Abstract] [Full Text]


Home page
ScienceHome page
J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma, P. Wilkinson, C. H. Hennekens, and M. Pollak
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Science, January 23, 1998; 279(5350): 563 - 566.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.